4.

4 Functional Polymer Materials

4.4.1

4.4.1

4.4.2

4.4.3

4.4.4

4.4.5

4.4.6

4.4.1

4.4.1

4.4.1

4.4.1

CH3

O
CH2

CH

CH2

O
O

CH2

CH CH2

+ CH2

CH COOH

CH3

OH

O
CH2

CH CO

CH2

CH

CH3
CH2

C
CH3

O
O

CH2

CH CH2

4.4.1

4.4.1

[ CH2

C H ]n

OH
CH2

CH

[ CH2

C H ]n
R

O CH2CH2
[ CH2

C lC H 2 C O O H

C H ]n

O C H 2CO O H

[ CH2

(R C O ) 2 O

C H ]n

PS

OCOR
[ CH2

RCOCl

C H ]n

(GTP)

OCOR
[ CH2

P 2 O 5, H 3 P O 4

LQLIHUWHU

OH

O
O

C H ]n

OH

7(032
RCHO

[ CH2

CH

CH2

CH ]n

5$)7

$753

CH
R

4.4.2

4.4.2

c
CH2

CH

CH3OCH2Cl

CH2

CH

KHCO3

CH2

Cl

H2O2, H

CH2

CH

CHO


ccd

CH

COOH
O

4.4.2

4.4.2

5
d

Ph

ClCrO3
N H

ClONMe3

NMe3

MnO4NMe3

Y +
X +

N CrO3

HN NH OCrO3-

Y +

BH4
NMe3

SnBu2H

Cr2O72-

4.4.2

4.4.2

HO

OH

Fe

Fe

CH2NR3 OH-

SO3H

O
CH
CH

Ph
C NBr

NBr

H
CH2 C

CF3
CF2CF2 m OCF2CF n
OCF2CF2SO3H

OAr
NMe3

AlCl3

ROAr

+ RX

/HZLV

4.4.2

4.4.2
O

(CH2)n NR'R" X

O
O

Q+X- + M+Nu

M+X- + Q+Nu-

Q+X- + R-Nu

R-X + Q+Nu



Fig. 3. Shape-selective olefin epoxidation using dendrimers

with a manganese(iii) porphyrin core as catalysts

4.4.2

Fig.4. Epoxidation results for the intermolecular mixture of

alkenes.The ratios of the epoxides are normalized with respect to
corresponding [Mn(TPP)]+ values. Errors are estimated at (5% relative.

4.4.3

QP

/-1cm-1

10-10




10-10102

102108

90%

108

(9.2 K)(23.3K)(0.26 K)

c
Fig.6 Competitive Hydrogenations of 3-Cyclohexene-1-methanol and CyclohexeneUsing Various Pd Catalysts .Reaction
conditions: 3-cyclohexene-1-methano l 0.5 mmol, cyclohexene 0.5 mmol, catalyst 5.0 mol of Pd, toluene 12.5 mL, H2 1
atm, 30 oC.

4.4.3

4.4.3

Sd

LQWULQVLFDOO\
FRQGXFWLQJSRO\PHU,&3d

)
(

H
N n

(
)

dc
cccc7&14d
lFP
FPd

H
N

)n

)n

10-1-1cm-1

4.4.3
O

C
O

4.4.3

O
C

520~530
-CO CO2

0/.DSODQ


37&'$
600-1200

H2

H2.0

d
1200oC

103-1cm-1

4.4.3

4.4.3
Thin polymer film is made by a solution-processable method.
soluble

photocrosslinking

4.4.3

4.4.3

Fast charged in less than 30 s
generate burst power at rated voltages
completely flexible, foldable, semi-transparent

PTC

4.4.3

4.4.3

1,2,3 dry polymer electrolyte

4,6,7 gel polymer electrolyte
8,9

liquid electrolyte

a, Pure (dry) polymer consisting of entangled chains, through which the Li ions (red points) move assisted by the motion of
polymer chains. b, A hybrid (gel) network consisting of a semicrystalline polymer, whose amorphous regions are swollen in a
liquid electrolyte, while the crystalline regions enhance the mechanical stability. c, A poly-olefin membrane (Celgard for instance)
in which the liquid electrolyte is held by capillaries.

1, First-generation PEO-LiCF3SO3;
2, new solutes with high-dissociation PEO-Li[(CF3SO2)2N]; 3, low-Tg combination
polymer;
4, plasticized polymer electrolyte PEO-Li[(CF3SO2)2N] + 25% w/w PEG-dimethylether (molecular weight, 250);
liquid crystalline polymer electrolytes; 5, heating curves; 6, cooling curve; 7, gel-type polymer (X-linked PEO-dimethacrylateLi[(CF3SO2)2N]-PC 70%); 8, liquid electrolyte PC/DME LiCF3SO3; 9, liquid electrolyte EC/DMC-LiPF6 at low temperature; 10,
gel electrolyte P(VDF-HFP)/EC/DMC-LiPF6 .

4.4.3

PTC (positive temperature coefficient)

4.4.3
PTC:

37&
d

Principle of a conductive-polymer PTC device. Distribution of ceramic particles at:

(a) normal operating temperature and

(b) trip temperature.



4.4.4

4.4.4

cc
cd

dcc
c

5000nm
100l5000nmc
2l100nmc
l 10c
l NaCld

c
d

d c cd

4.4.4

4.4.4

PEM

3(0
d
1DILRQ

c 700/m2
l
d

:
c


Shutoff

> Tm

Nafion

a: PP b: PE c: PP/PE/PP

4.4.4

4.4.4
PP/PE/PP

dry process

wet process

4.4.5

4.4.5
cd

c
ccc
d
c
d

d
1ccc
ccc
2
cccc
d
cd
3c

4.4.5
Biodegradable polymer materials
BONE+PLATE
Mechanical Strength

4.4.5

ccc
c

Degradable Polymer
Plate

PLATE

BONE

1
Time

Maxillofacial Fracture Fixation

cc
cc/d
PLA

4.4.5

cd
cd

lPPPPd

4.4.5
(2)

38d

d

cc

d
c
BPOcd

d
-504

4.4.5

4.4.5

d
d

cccd
A

(a)

(b)
BPOd

(c)
,

d
d,
d

4.4.5

4.4.5

(a)

(b)
d

4.4.5

4.4.5

(c) ccpH
d

PH-sensitivity

4.4.6

4.4.5

d
l
d
d

d
Drug molecule

 S+l

S+l

d
lPd
d

d

d

d
EXCLUSIVE DRUG DELIVERY TO SPECIFIC CELL TYPES

4.4.6

4.4.6

d
H2SO4, C2H4Cl2

c
d
dc
cccd

SO3H

H2O

RSO3H

HSO3Cl, C2H4Cl2

RPO(OH)2

CH
CH2

RCOOH

CH

SO2H

CH2

CH2

CH

CH2

CH

COOH

+
CH

CH2

CH2

CH

CH2

CH

CH2

CH2

CH

CH

CH2

R3NCl

RNH2RNRHRNR2

CH2

CH

CH2

CH

CH2Cl

)
N(C H 3
+

CH 2N (CH 3 )3Cl
N(C H

3 )C2 H

CH 2 Cl

4 OH

CH 2N + (CH 3) 2(C 2 H 4 O H)Cl -

4.4.6

C6H5

+ CH3OH

ZnCl2

C 6H 5

CH

CH3OCH2Cl

C6H5

C6H5

C6H5

C6H5

HOOC

HOOC

COOH

C6H5

C6H5

COOH

COOH
COOH

COOH
COOH

COOH